000			06051nam a22002897a 4500
003			OSt
005			20240305192519.0
008			220728b |||||||| |||| 00| 0 eng d
020			_a 1437721494
020			_a9781437721492
040			_cdlc
050			_aRC685.C6A288 2011
050			_a WG 300 A185884 2011
082			_222 _a 616.1′23 THE
100			_a Pierre Theroux _940602
222			_aactivation acute coronary syndromes acute myocardial infarction addition agents antiplatelet aspirin assessment associated atherosclerosis benefit bleeding blood cardiac Cardiol cardiovascular cause cells chest pain Circulation clinical clopidogrel Coll Cardiol compared controlled coronary artery disease death diabetes dose drug early effects elevation endothelial Engl et al evaluation evidence exercise factor failure function guidelines Heart heparin higher hospital human IIb/IIIa imaging important improved increased inflammatory inhibition inhibitors initial intervention invasive ischemia ischemic less levels lower major markers measured months mortality observed outcome patients with acute percutaneous plaque platelet predict present primary protein randomized recent receptor recommended reduced reperfusion reperfusion injury reported response revascularization risk role score severe showed shown significant STEMI stent strategy stress suggest testing therapy tion tissue treated treatment trial troponin undergoing unstable angina vascular versus
245			_aAcute Coronary Syndromes _b A Companion to Braunwald's Heart Disease
250			_a2nd edition
260			_a1600 John F. Kennedy Blvd. Ste 1800 Philadelphia, PA 19103-289 _bElsevier Health Sciences _c2010
300			_a 448 pages
505			_aContents: The Past the Present the Future Risk Factors Predicting Nonfatal Myocardial Infarction The INTERHEART Study Results from the Reduction of Atherothrombosis for Continued Health REACH Registry Historical Perspective and Lessons Learned from the Euro Heart Surveys on Acute Coronary Syndromes Acute Coronary Syndrome in North America Pathogenesis of Stable and Acute Coronary Syndromes Molecular Mechanisms of the Acute Coronary Syndromes The Roles of Inflammation and Immunity The Immune System in Acute Coronary Syndrome Antiplatelet Therapy Nonresponsiveness to Antiplatelet Therapy Anticoagulants Beta Blockers Calcium Channel Blockers Ranolazine Nitrates and Nitric Oxide Donors Use in Acute Coronary Syndromes Adenosine TriphosphateSensitive Potassium Channels Adenosine and Preconditioning Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome Plaque Passivation and Endothelial Therapy Revascularization in NonSTSegment Elevation Acute Coronary SyndromeFor Whom When and How? Myocardial Cell Death and Regeneration Pharmacogenomics Clinical Recognition of Acute Coronary Syndromes Biomarkers in Acute Ischemic Heart Disease Prognostic Risk Stratification After Acute Coronary Syndromes The Role of Noninvasive Testing Echocardiography in Acute Coronary Syndromes Nuclear Cardiology Techniques in Acute Coronary Syndromes Multislice Computed Tomography in Acute Coronary Syndromes Emerging Diagnostic Procedures for the Vulnerable Plaque Risk Stratification in Unstable Angina and NonSTSegment Elevation Myocardial Infarction Treatment Principles and Emerging Therapies in Acute Coronary Syndromes without STSegment Elevation Percutaneous Coronary Intervention and Concomitant Antithrombotic Therapy Bleeding in the Acute Coronary Syndromes The Patient with Disabling Refractory Angina Not Amenable to Revascularization Procedures Dietary Intervention in Coronary Care Units and in Secondary Prevention Exercise Training After an Acute Coronary Syndrome Diagnosis and Treatment of NonSTSegment Elevation Acute Coronary Syndromes European Society of Cardiology Guidelines ACCAHA 2007 Guidelines for the Management of Patients with Unstable AnginaNonSTSegment Elevation Myocardial Infarction A Summary Article The Modern Cardiac Care Unit Index
520			_aAcute Coronary Syndromes—a Companion to Braunwald’s Heart Disease—covers the state-of-the-art scientific and clinical information you need to rapidly evaluate and manage acute coronary syndromes. Dr. Pierre Theroux and his team of expert contributors present advances in diagnostic and imaging techniques such as biomarkers, nuclear cardiology, echocardiography, and multislice CT; secondary prevention; and new antiplatelet, anti-ischemic, and gene therapies. Tap into the most definitive knowledge available from one of the leading experts in the field and a stellar cast of contributors. Understand the special considerations for the care of acute coronary syndromes in the emergency department and the coronary care unit. Effectively handle the treatment of special populations and chronic patients thanks to coverage of these challenges See techniques and procedures in greater detail and clarity through the all-new full-color design. Approach treatment with a global perspective from the new section on Population-Based Perspective that discusses the INTERHEART study, insights from the REACH registry, lessons learned from European registries, and ACS in North America. Gain a comprehensive understanding of ACS through coverage of pathophysiology, molecular mechanisms, the role of the immune system, and brand-new chapters on cell necrosis and cell regeneration and pharmacogenetics in the section on Disease-Based Perspectives. Integrate the latest testing and treatment techniques into your practice thanks to new chapters on biomarkers in acute ischemic heart disease; the role of noninvasive testing in prognostic risk stratification; the culprit lesions and patient at risk; non-responsiveness to antiplatelet therapy; bleeding in the acute coronary syndromes; and the refractory patient.
600			_xAcute Coronary Syndrome. _940603
600			_x Medical › Cardiology _927540
600			_x Medical / Cardiology _926817
942			_2ddc _cEB
999			_c7804 _d7804